ALZHEIMER'S DISEASE NOVEL DRUGS: A REVIEW

Alzheimer's disease (AD) is a neurological illness that causes the majority of dementia cases. In today's increasingly ageing population, the prevalence of Alzheimer's disease has increased, putting a great strain on families and society. Despite the devastating symptoms of Alzheimer's disease, present treatments are unable to generate sufficient therapeutic benefits or halt the illness's progression. Finding new treatments for Alzheimer's disease has become critical. In this research, we looked at five different types of innovative therapeutic approaches: anti-amyloid therapy, anti-tau therapy, anti-neuroinflammatory therapy, neuroprotective drugs such as N-methyl-D-aspartate (NMDA) receptor modulators, and brain stimulation. The focus of therapeutic development is changing away from a single disease target and toward more complicated mechanisms like neuroinflammation and neurodegeneration. The review focus on Novel Drug used for treatment of alzheimer’s disease